Journal of Surgery Concepts & Practice ›› 2022, Vol. 27 ›› Issue (05): 478-482.doi: 10.16139/j.1007-9610.2022.05.019
• Review • Previous Articles
ZHANG Jixiang1, XIE Zhihua1, LI Wei, JIANG Xiaoqing1,2
Received:
2021-06-07
Online:
2022-09-25
Published:
2022-11-10
CLC Number:
ZHANG Jixiang, XIE Zhihua, LI Wei, JIANG Xiaoqing. Classification of intrahepatic cholangiocarcinoma and hot topics in surgical treatment[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 478-482.
[1] | Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol, 2014, 60(6):1268-1289. |
[2] | Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma[J]. Semin Liver Dis, 2004, 24(2):115-125. |
[3] | Sirica AE, Gores GJ, Groopman JD, et al. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances[J]. Hepatology, 2019, 69(4):1803-1815. |
[4] | Plentz RR, Malek NP. Clinical presentation, risk factors and staging systems of cholangiocarcinoma[J]. Best Pract Res Clin Gastroenterol, 2015, 29(2):245-252. |
[5] | Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: Cholangiocarcinoma: current know-ledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(5):261-280. |
[6] | Lim JH, Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging fin-dings[J]. Am J Roentgenol, 2003, 181(3):819-827. |
[7] | Krasinskas AM. Cholangiocarcinoma[J]. Surg Pathol Clin, 2018, 11(2):403-429. |
[8] | Sia D, Hoshida Y, Villanueva A, et al. Integrative mole-cular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes[J]. Gastroenterology, 2013, 144(4):829-840. |
[9] | Rhee H, Ko JE, Chung T, et al. Transcriptomic and histopathological analysis of cholangiolocellular differen-tiation trait in intrahepatic cholangiocarcinoma[J]. Liver Int, 2018, 38(1):113-124. |
[10] | Si A, Li J, Yang Z, et al. Impact of anatomical versus non-anatomical liver resection on short- and long- term outcomes for patients with intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(6):1841-1850. |
[11] | 吴向嵩, 陈燕, 靳云鹏, 等. 解剖性肝切除在肝内胆管癌治疗中的价值[J]. 中华外科杂志, 2018, 56(4):269-273. |
[12] | Li B, Song J, Aierken Y, et al. Nonanatomic resection is not inferior to anatomic resection for primary intrahepatic cholangiocarcinoma: a propensity score analysis[J]. Sci Rep, 2018, 8(1):17799. |
[13] | Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group[J]. Ann Surg, 2011, 254(5):824-830. |
[14] | Weber SM, Ribero D, O′Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement[J]. HPB (Oxford), 2015, 17(8):669-680. |
[15] | Valle JW, Borbath I, Khan SA, et al. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2016, 27(suppl 5):v28-v37. |
[16] | Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study[J]. Surgery, 2019, 166(6):975-982. |
[17] | Kim SH, Han DH, Choi GH, et al. Oncologic impact of lymph node dissection for intrahepatic cholangiocarcinoma: a propensity score-matched study[J]. J Gastrointest Surg, 2019, 23(3):538-544. |
[18] | Zhou R, Lu D, Li W, et al. Is lymph node dissection ne-cessary for resectable intrahepatic cholangiocarcinoma? a systematic review and meta-analysis[J]. HPB (Oxford), 2019, 21(7):784-792. |
[19] | Okami J, Dono K, Sakon M, et al. Patterns of regional lymph node involvementin intrahepatic cholangiocarcinoma of the left lobe[J]. J Gastrointest Surg, 2003, 7(7):850-856. |
[20] | Tsuji T, Hiraoka T, Kanemitsu K, et al. Lymphatic spreading pattern of intrahepatic cholangiocarcinoma[J]. Surgery, 2001, 129(4):401-407. |
[21] | Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates[J]. Chin Clin Oncol, 2018, 7(5):52. |
[22] | Kang SH, Choi Y, Lee W, et al. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching[J]. Surg Oncol, 2020, 33:63-69. |
[23] | Martin SP, Drake J, Wach MM, et al. Laparoscopic approach to intrahepatic cholangiocarcinoma is associated with an exacerbation of inadequate nodal staging[J]. Ann Surg Oncol, 2019, 26(6):1851-1857. |
[24] | Weimann A, Varnholt H, Schlitt HJ, et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma[J]. Br J Surg, 2000, 87(9):1182-1187. |
[25] | Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience[J]. Liver Transpl, 2005, 11(11):1412-1416. |
[26] | Sapisochin G, Facciuto M, Rubbia-Brandt L, et al. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment[J]. Hepatology, 2016, 64(4):1178-1188. |
[27] | Lunsford KE, Javle M, Heyne K, et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case series[J]. Lancet Gastroenterol Hepatol, 2018, 3(5):337-348. |
[28] | Yamamoto M, Takasaki K, Otsubo T, et al. Recurrence after surgical resection of intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pancreat Surg, 2001, 8(2):154-157. |
[29] | Doussot A, Gonen M, Wiggers JK, et al. Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models[J]. J Am Coll Surg, 2016, 223(3):493-505. |
[30] | Spolverato G, Kim Y, Alexandrescu S, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection[J]. Ann Surg Oncol, 2016, 23(1):235-243. |
[31] | Si A, Li J, Xing X, et al. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: factors associated with long-term outcomes[J]. Surgery, 2017, 161(4):897-908. |
[32] | Buettner S, Koerkamp BG, Ejaz A, et al. The effect of preoperative chemotherapy treatment in surgically treated 308 intrahepatic cholangiocarcinoma patients-a multi-institutional analysis[J]. J Surg Oncol, 2017, 115(3):312-318. |
[33] | Le Roy B, Gelli M, Pittau G, et al. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma[J]. Br J Surg, 2018, 105(7):839-847. |
[34] | Sumiyoshi T, Shima Y, Okabayashi T, et al. Chemoradiotherapy for initially unresectable locally advanced cholangiocarcinoma[J]. World J Surg, 2018, 42(9):2910-2918. |
[35] | Abou-Alfa GK, Sahai V, Hollebecque A, et al. Pemigatinib for previously treated, locally advanced or metasta-tic cholangiocarcinoma: a multicentre, open-label, phase 2 study[J]. Lancet Oncol, 2020, 21(5):671-684. |
[36] | Javle M, Lowery M, Shroff RT, et al. Phase Ⅱ study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma[J]. J Clin Oncol, 2018, 36(3):276-282. |
[37] | Kim RD, Chung V, Alese OB, et al. A Phase 2 multi institutional study of nivolumab for patients with advanced refractory biliary tract cancer[J]. JAMA Oncol, 2020, 6(6):888-894. |
[38] | Ueno M, Ikeda M, Morizane C, et al. Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study[J]. Lancet Gastroenterol Hepatol, 2019, 4(8):611-621. |
[39] | Lin J, Yang X, Long J, et al. Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma[J]. Hepatobiliary Surg Nutr, 2020, 9(4):414-424. |
[1] | XING Ying, CHENG Shi. Neoadjuvant therapy for gallbladder cancer: current status and challenge [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 110-114. |
[2] | WANG Yuanjiang, ZOU Hao. Clinical study on comprehensive treatment of gallbladder cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 171-176. |
[3] | LU Yiming, XIONG Jianping, TIAN Yantao. Current status and prospect of conversion therapy for far-advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 17-23. |
[4] | ZHU Zhenggang. Progress and prospect of surgical comprehensive treatment of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 1-6. |
[5] | ZHAO Fazhi, ZHAO Ping. Formation and improvement of surgery-based treatment system for gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 24-30. |
[6] | LIU Wentao, LIU Fukun. Summary and prospect of perioperative comprehensive treatment for gastric cancer in China [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 36-41. |
[7] | CHENG Wei, HUANG Yuhua, WANG Jian, LI Yousheng. Multivariate analysis of prognosis of patients with malignant bowel obstruction [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 340-345. |
[8] | GUO Yang, GUO Tian′an, XU Ye. Recent advance in neoadjuvant chemotherapy for rectal cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 370-374. |
[9] | YIN Yanjiang, LUO Zhiwen, CHEN Xiao, ZHANG Yefan, HUANG Zhen, ZHAO Hong, ZHAO Jianjun, LI Zhiyu, ZHOU Jianguo, CAI Jianqiang, BI Xinyu. Relationship between surgical margin and prognosis of patients with intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 221-228. |
[10] | XU Zifeng, ZONG Yaping, LU Aiguo. Neoadjuvant therapy in patients with locally advanced colon cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 266-270. |
[11] | CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben. Diagnosis and treatment of medullary thyroid carcinoma-an update [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 276-280. |
[12] | WANG Guifu, LIU Renjie, BAI Dousheng, JIANG Guoqing, ZHANG Chi, WANG Qian, WANG Aoqing, JIN Shengjie. Gallstone ileus: diagnosis and treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 169-172. |
[13] | LIU Hongzhi, LIN Ziguo, HUANG Jianlong, ZHOU Weiping, CHENG Zhangjun, LOU Jianying, ZHENG Shuguo, BI Xinyu, WANG Jianming, GUO Wei, LI Fuyu, WANG Jian, ZHENG Yamin, LI Jingdong, CHENG Shi, LIU Jingfeng, ZENG Yongyi. Effect of surgical margin width on prognosis in patients with single intrahepatic cholangiocarcinoma from a multicenter study [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 130-137. |
[14] | SI Anfeng, LEI Zhengqing, YANG Pinghua, JIANG Tao, WANG Xuan, CHENG Zhangjun. Effectiveness of postoperative transarterial chemoembolization for huge intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 138-143. |
[15] | ZHANG Lipeng, WANG Zhongmin, ZHAO Xinjian. Splenic artery embolization versus surgery in treatment of traumatic splenic injury: a comparative study [J]. Journal of Surgery Concepts & Practice, 2020, 25(03): 222-226. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||